In this issue:
Association of neuronal autoantibodies with cognitive impairment in lung cancer
Adding metformin to chemoradiation in locally advanced NSCLC: two studies
Metformin in combination with chemoradiotherapy in locally advanced non-small cell lung cancer
Pembrolizumab + chemoradiation in unresectable, locally advanced NSCLC
Nivolumab ± ipilimumab for previously treated stage IV SCLC
Durvalumab + neoadjuvant chemotherapy in stage IIIA(N2) NSCLC
Prechemotherapy trilaciclib reduces need for supportive care for myelosuppression in SCLC
Optimal surgical timing and RT dose for trimodal therapy in locally advanced NSCLC
Sequential afatinib and osimertinib or other regimens in EGFR-mutated NSCLC
ctDNA for identifying somatic mutations and tracking tumour evolution in NSCLC
Please login below to download this issue (PDF)